deferiprone has been researched along with (pPNET) Peripheral Primitive Neuroectodermal Tumors in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J | 1 |
| Obando, D | 1 |
| Schipanski, LG | 1 |
| Groebler, LK | 1 |
| Witting, PK | 1 |
| Kalinowski, DS | 1 |
| Richardson, DR | 1 |
| Codd, R | 1 |
1 other study available for deferiprone and (pPNET) Peripheral Primitive Neuroectodermal Tumors
| Article | Year |
|---|---|
Conjugates of desferrioxamine B (DFOB) with derivatives of adamantane or with orally available chelators as potential agents for treating iron overload.
Topics: Adamantane; Administration, Oral; Animals; Binding Sites; Carboxylic Acids; Cell Proliferation; Cell | 2010 |